Focus Stocks
Amgen near Key Support Area
Published on Thursday, 02 September 2010 05:56 Written by Danny Miller
New York, September 2nd (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated support at $50.26 with current price action closing at just $52.59 places the stock price near levels where traders will start paying attention.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
Amgen's current stock range is defined by current calculated support defined at $50.26 and by the resistance level at $56.14, which should be used by traders planning their trades.
Traders wanting to establish a position should place close attention to Amgen's price action, and establish a position as close to support as possible, but only after buying materializes. Traders should understand that the resistance point at $56.14 might limit their upside, however if the stock breaks resistance, it could be a good point to add to the position.
Related Articles
- NASDAQ 100 Mid-day Update: Lower Top Performers: VRTX, FSLR, GILD
- Amgen near Resistance
- Is Amgen Breaking Out?
- Trading Idea - Is Amgen close to Resistance?
- Amgen Higher Ahead of Earnings
- Amgen near Key Resistance Area
- Up/Downgrades ( COP, FST, CMA, PNRA, ARW, AVT, ALTH, ACOR, AMGN, FST )
- Is Amgen Breaking Out?
- Amgen - Shares Seeking Direction
- Amgen - 52 Week High
Related Partner Headlines
- Deutsche Bank: Xgeva Not Proceeding Well for Amgen - Benzinga
- Amgen to Discuss Application for New Use of XGEVA at FDA Oncologic Drugs Advisory Committee Meeting - Benzinga
- Dendreon Rockets 17% After Critical Reveiw For Amgen's Cancer Drug - Benzinga
- Piper Jaffray Postive on Amgen After FDA Releases Briefing Documents on Xgeva - Benzinga
- FDA Skeptical of Amgen Drug Ahead of Panel - TheStreet.com
- Amgen Reaches New 52-Week High (AMGN) - TheStreet.com
- Stock Market Story: Jan. 27 - TheStreet.com
- Stocks to Watch: P&G, Ford, Starbucks - TheStreet.com
- Amgen Acquires Micromet for $1.16 Billion - TheStreet.com
- Limitations of Beta-Weighted Delta Hedging - TheStreet.com
TradersHuddle Search
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
gategroup Seeks to Extend and Amend Credit Facilities -
Publicis Groupe: 2011 Annual Results -
VIDEO from Siemens and Synaptic Digital: US Transportation Secretary LaHood to Visit Siemens Light Rail Manufacturing Plant in Sacramento -
Comstock Mining Announces Pricing of Public Offering of Common Stock -
Boeing 787 Dreamliner Debuts in Bangkok for Dream Tour -
SYNC Accelerates into 2013 as Standard Equipment on New Ford Fusion and Flex -
Bacteria Detection Time Cut From Days to Minutes -
Pantone Announces Fashion Color Report Fall 2012










